GMAB•benzinga•May 2, 2025 at 06:01 AM

Reported Earlier, Genmab To Submit sBLA To FDA for Epcoritamab Plus R2 In Relapsed/Refractory Follicular Lymphoma Following Positive Phase 3 Data

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 2, 2025 by benzinga